CoreCivic Rakes In Profits as ICE Detention Demand Surges, Activates Idle Prisons

CoreCivic, one of the nation’s largest private prison operators, is cashing in on the Trump administration’s aggressive immigration enforcement with a sharp uptick in ICE detainees and the reopening of multiple idle detention centers. The company’s Q1 2026 earnings call revealed a 74% jump in adjusted earnings per share to $0.40, far surpassing analyst expectations, driven largely by increased federal contracts and expanded capacity.

CoreCivic CEO Patrick Swindle highlighted that the average daily population across their facilities rose to 57,243 individuals, up from 51,429 a year earlier. Notably, ICE detainee numbers swelled by about 4,500 individuals—a 45% increase—to nearly 14,700 by March 31. This surge in ICE populations directly translated into a 96% increase in revenue from ICE, reaching $128.1 million for the quarter.

To meet this swelling demand, CoreCivic has reactivated five previously idle facilities, including the 2,560-bed California City Detention Facility and the 2,160-bed Diamondback Correctional Facility. These reopenings, along with the July 2025 acquisition of the Farmville Detention Center, have significantly boosted the company’s operational capacity and revenue streams.

Despite a recent dip in ICE detainee numbers attributed to a Department of Homeland Security funding standoff and agency reshuffling, CoreCivic management expects this decline to be temporary. The company also maintains approximately 7,000 idle beds across five facilities, ready to be filled as government demand dictates.

CoreCivic’s expansion isn’t limited to detention centers. The company’s acquisition of Clinical Solutions Pharmacy for $148 million positions it as a major provider of mail-order pharmacy services to correctional facilities nationwide. This move diversifies CoreCivic’s revenue, with the pharmacy expected to generate up to $230 million in 2026 revenue and contribute modestly to earnings per share.

The company raised its full-year earnings guidance, projecting adjusted diluted EPS between $1.53 and $1.63, reflecting the strong quarter, facility activations, and the pharmacy acquisition. CoreCivic’s growing profits reveal how private prison operators continue to benefit financially from harsh immigration policies and the expansion of detention infrastructure.

As ICE populations rise and government contracts pour in, CoreCivic’s Q1 results lay bare the lucrative business model built on incarceration and immigrant detention—highlighting the urgent need for accountability and transparency in the privatized detention industry.